[1]
R. K. Bhardwaj, “A Comparative study of Rosuvastatin and Fenofibrate as Monotherapy in Dyslipidemia and NCEP ATP III Goals”, J. Drug Delivery Ther., vol. 3, no. 4, pp. 108–113, Jul. 2013, doi: 10.22270/jddt.v3i4.583.